Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Qufeng Rougan Xiaobai Fang (祛风柔肝消白方) is a Traditional Chinese Medicine (TCM) herbal formula developed by the Chongqing Hospital of Traditional Chinese Medicine. It is specifically investigated for the treatment of progressive vitiligo, a condition characterized by the active loss of skin pigmentation. The formula's name reflects its therapeutic intent according to TCM principles: 'Qufeng' (expelling wind), 'Rougan' (softening or nourishing the liver), and 'Xiaobai' (eliminating white patches). It is typically administered orally and is being evaluated in clinical trials (such as ChiCTR2200062211) to assess its ability to stabilize disease progression and promote repigmentation in patients with active vitiligo.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on qufeng rougan xiaobai fang.